Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Intellia Therapeutics, Inc. | 207,453 | reported | 05 Jan 2026 | tx 17+323,961−20,000 |
| CareDx, Inc. | 155,265 | reported | 13 Jun 2025 | tx 53+297,234−78,392 |
| BIOCRYST PHARMACEUTICALS INC | 30,000 | reported | 20 Jun 2018 | tx 23+314,493−208,500 |
| Progyny, Inc. | 25,070 | reported | 23 May 2024 | tx 13+128,803 |
| TANDEM DIABETES CARE INC | 25,000 | reported | 15 Nov 2018 | tx 7+100,000 |
| Kyverna Therapeutics, Inc. | 20,582 | reported | 27 May 2026 | tx 8+4,631,584−20,588,834 |
| UroGen Pharma Ltd. | 10,000 | reported | 06 Aug 2024 | tx 9+144,339−15,000 |
| FIVE PRIME THERAPEUTICS INC | 10,000 | reported | 10 May 2017 | tx 14+69,807−24,695 |
| Roka BioScience, Inc. | 3,000 | reported | 28 Jun 2017 | tx 3+48,000 |
| VERACYTE, INC. | 0 | reported | 19 Oct 2020 | tx 19+120,000−90,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Kyverna Therapeutics, Inc. | 5,093 | 0.00 USD | |
| 27 May 2026 | GRANT_AWARD | Kyverna Therapeutics, Inc. | 20,582 | 0.00 USD | deriv |
| 05 Jan 2026 | PURCHASE | Intellia Therapeutics, Inc. | 150,000 | 9.35 USD | |
| 13 Jun 2025 | GRANT_AWARD | CareDx, Inc. | 12,103 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Intellia Therapeutics, Inc. | 8,000 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Intellia Therapeutics, Inc. | 11,450 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Kyverna Therapeutics, Inc. | 16,634 | 0.00 USD | |
| 29 May 2025 | GRANT_AWARD | Kyverna Therapeutics, Inc. | 65,351 | 0.00 USD | deriv |
| 06 Aug 2024 | GRANT_AWARD | UroGen Pharma Ltd. | 10,000 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | CareDx, Inc. | 10,570 | 0.00 USD | |
| 14 Jun 2024 | GRANT_AWARD | CareDx, Inc. | 16,048 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 7,737 | 0.00 USD | |
| 12 Jun 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 11,515 | 0.00 USD | deriv |
| 23 May 2024 | GRANT_AWARD | Progyny, Inc. | 6,176 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | Progyny, Inc. | 25,070 | 0.00 USD | deriv |
| 12 Feb 2024 | CONVERSION | Kyverna Therapeutics, Inc. | 4,523,924 | — | |
| 12 Feb 2024 | CONVERSION | Kyverna Therapeutics, Inc. | 8,830,901 | 0.00 USD | deriv |
| 12 Feb 2024 | CONVERSION | Kyverna Therapeutics, Inc. | 4,401,771 | 0.00 USD | deriv |
| 12 Feb 2024 | CONVERSION | Kyverna Therapeutics, Inc. | 7,356,162 | 0.00 USD | deriv |
| 07 Sept 2023 | GRANT_AWARD | UroGen Pharma Ltd. | 10,000 | 0.00 USD | deriv |
| 26 Jul 2023 | GRANT_AWARD | UroGen Pharma Ltd. | 69,339 | 9.54 USD | |
| 16 Jun 2023 | GRANT_AWARD | CareDx, Inc. | 18,844 | 0.00 USD | |
| 16 Jun 2023 | GRANT_AWARD | CareDx, Inc. | 29,136 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 4,425 | 0.00 USD | |
| 14 Jun 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 6,473 | 0.00 USD | deriv |